CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $39,150 (100.0% shares, 0.0% debt)

Holdings (17)

SVRA SAVARA INC 27.3%
Value ($000) $10,690 Shares 6,896,551 Est. Cost $1.66 Unrealized -17.6%
XERS XERIS BIOPHARMA HOLDINGS INC 20.5%
Value ($000) $8,032 Shares 6,039,028 Est. Cost $2.16 Unrealized -34.6%
SPY SPDR S&P 500 ETF TR 15.6%
Value ($000) $6,099 Shares 15,947 Est. Cost $451.81 Unrealized
RZLT REZOLUTE INC 7.4%
Value ($000) $2,905 Shares 1,403,157 Est. Cost $9.52 Unrealized -80.3%
SCYX SCYNEXIS INC 6.9%
Value ($000) $2,689 Shares 1,723,947 Est. Cost $6.13 Unrealized -63.9%
XOP SPDR SER TR 6.1%
Value ($000) $2,378 Shares 17,500 Est. Cost $124.74 Unrealized
VECTIVBIO HLDG AG 3.4%
Value ($000) $1,346 Shares 156,222 Est. Cost $5.72 Unrealized
ACLX ARCELLX INC 2.9%
Value ($000) $1,125 Shares 36,302 Est. Cost $16.24 Unrealized +41.3%
AMLP ALPS ETF TR 2.9%
Value ($000) $1,123 Shares 29,500 Est. Cost $36.58 Unrealized
CMPX COMPASS THERAPEUTICS INC 2.7%
Value ($000) $1,062 Shares 211,159 Est. Cost $3.99 Unrealized 0.0%
CABA CABALETTA BIO INC 2.0%
Value ($000) $784 Shares 84,728 Est. Cost $3.64 Unrealized 0.0%
MOLECULAR TEMPLATES INC 1.7%
Value ($000) $673 Shares 2,052,991 Est. Cost $8.09 Unrealized
ALLAKOS INC 0.4%
Value ($000) $154 Shares 18,271 Est. Cost $8.42 Unrealized
ELEVATION ONCOLOGY INC 0.2%
Value ($000) $65 Shares 68,324 Est. Cost $9.95 Unrealized
NAMSW NEWAMSTERDAM PHARMA COMPANY 0.0%
Value ($000) $18 Shares 21,333 Est. Cost $0.83 Unrealized
BRIDGETOWN HOLDINGS LTD 0.0%
Value ($000) $5 Shares 39,773 Est. Cost $4.40 Unrealized
LANV/WS LANVIN GROUP HOLDINGS LIMITE 0.0%
Value ($000) $4 Shares 12,000 Est. Cost $0.31 Unrealized